[Naldemedine (Rizmoic®) for the treatment of opioid-induced constipation].

Opioid-induced constipation (OIC) is a common but often overlooked issue in patients undergoing treatment for chronic pain. Effectively managing pain also means paying attention to adverse effects such as OIC, which can impact patients' quality of life. In addition to traditional treatments, therapeutic alternatives like naldemedine, a selective peripherally acting μ-opioid receptor antagonist, are now available to help patients for whom standard solutions are insufficient.